Colorectal Cancer (CRC)

Empowering Oncology Providers: Digital Guide to Cancer Care. Learn more >

This site is funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment.

podcasts

Arvind Dasari

Arvind Dasari, MD MS

Dr. Dasari is a medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. He is co-Chair of the MD Anderson multidisciplinary neuroendocrine tumor board and his clinical focus is on neuroendocrine malignancies. Dr. Dasari’s research interests include clinical, translational and outcomes work in gastrointestinal cancers... Read more >

Reetu Mukherij

Reetu Mukherji, MD

Dr. Mukherji is a gastrointestinal medical oncologist and Assistant Professor of Medicine at MedStar Georgetown University Hospital. She also leads the medical oncology department’s clinical and research focus on upper gastrointestinal malignancies, including esophageal and gastric cancers, at the Georgetown Lombardi Comprehensive Cancer Center... Read more >

Ben George

Ben George, MD

Dr. George is a gastrointestinal medical oncologist and Associate Professor of Medicine at the Medical College of Wisconsin. His practice has entirely consisted of gastrointestinal malignancies for over a decade. He is also Medical Director of the clinical trials office at the Medical College of Wisconsin, where his research focuses on novel biomarkers... Read more >

Explore more of our podcast episodes across these platforms:

modules

Fast Facts: Colorectal Cancer — How to Navigate the Shifting Treatment Landscape

Top
Ben George

Ben George, MD

Dr. George is a gastrointestinal medical oncologist and Associate Professor of Medicine at the Medical College of Wisconsin. His practice has entirely consisted of gastrointestinal malignancies for over a decade. He is also Medical Director of the clinical trials office at the Medical College of Wisconsin, where his research focuses on novel biomarkers and novel treatments for gastrointestinal cancers. Dr. George has been involved with several trials that have advanced the treatment of gastrointestinal cancers, and he is passionate about continuing to push for advancements in cancer care.

Reetu Mukherij

Reetu Mukherji, MD

Dr. Mukherji is a gastrointestinal medical oncologist and Assistant Professor of Medicine at MedStar Georgetown University Hospital. She also leads the medical oncology department’s clinical and research focus on upper gastrointestinal malignancies, including esophageal and gastric cancers, at the Georgetown Lombardi Comprehensive Cancer Center. In her clinical work, she primarily cares for patients with gastrointestinal cancers. Dr. Mukherji’s research interests are in patients with gastrointestinal tumors—looking at novel therapeutics and novel biomarkers. Dr. Mukherji strongly believes in the value of working collaboratively with patients, their support systems, and multi-disciplinary teams to deliver the highest level of care and support through their cancer diagnosis.

Arvind Dasari

Arvind Dasari, MD MS

Dr. Dasari is a medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. He is co-Chair of the MD Anderson multidisciplinary neuroendocrine tumor board and his clinical focus is on neuroendocrine malignancies. Dr. Dasari’s research interests include clinical, translational and outcomes work in gastrointestinal cancers. He is currently a member of the NCI Task Force for Neuroendocrine Tumors, is co-Chair of the SWOG Neuroendocrine Subcommittee and also chairs the NANETS’ Continuing Education Committee. Dr. Dasari is passionate about the advancement of treatment options for patients with cancer.

Melinda Bachini

Melinda Bachini

Melinda Bachini is a 13-year survivor of cholangiocarcinoma. In 2012 she was treated at the National Cancer Institute by Dr. Rosenberg in a clinical trial using Adoptive Cell Therapy with TIL. Due to an exceptional and breakthrough response to this treatment, her story was published in the New York Times and other media.

Marina Baretti, MD

Marina Baretti, MD

Dr. Marina Baretti is an Assistant Professor of Oncology at Johns Hopkins University School of Medicine in Baltimore, USA. Dr. Baretti completed medical school at the University of Pisa, Italy, and she continued her medical training in Internal Medicine and Oncology at the University of Milan.

Sameek Roychowdhury, MD PhD

Sameek Roychowdhury, MD PhD

Dr. Sameek Roychowdhury received his M.D. at The Ohio State University. He completed his Ph.D. dissertation research with his mentor Michael Caligiuri, M.D., studying cancer immunology and experimental therapeutics. He completed his internal medicine and medical oncology fellowship training at University of Michigan.

Taiho - Logo